Acute heart failure – a call to action

Br J Cardiol 2013;20(suppl 2):S1–S11doi:10.5837/bjc.2013.s02 Leave a comment
Click any image to enlarge
Authors:
Sponsorship Statement: This supplement is based on the proceedings of a one-day consensus meeting on acute heart failure held at the Royal College of Physicians, London, on 19th December 2012. The meeting was convened by Professor Martin Cowie and Logos Communications, who approached Novartis Pharmaceuticals for support. Novartis had no input into the content of the meeting or in the selection of the participants but provided an educational grant to cover the meeting costs, honoraria and travel expenses, and the services of medical writer, Jenny Bryan, who wrote up the meeting for this supplement. The authors all reviewed and approved this supplement before publication.  Novartis also reviewed the supplement for technical accuracy and ABPI compliance, and sponsored the development of this supplement in the BJC and its distribution.

Insights from the world of cardiology

Pay to access this premium content £5

The BJC is introducing a small charge for some of its premium content. On purchase you will receive an email to access the article and have a downloadable PDF to keep. The PDF can be downloaded from a button on the sidebar. Please note the purchase of this article is for your personal use only.
By supporting us in this way, you are helping us to deliver high-quality services to healthcare professionals. We will continue to keep the majority of our content free of charge.


You can access this article without logging in.
But don't miss out on the many Benefits of our Membership. Register Now.
Already a member? Login Now.
Disclaimer: Medinews Cardiology Limited advises healthcare professionals to consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews Cardiology Limited cannot accept responsibility for any errors in prescribing which may occur.
THERE ARE CURRENTLY NO COMMENTS FOR THIS ARTICLE - LEAVE A COMMENT